Table 2.
Clinical characteristics, use of therapeutic procedures and hospital outcomes after matching by age and myocardial infarction type (ICD 10) for men and women hospitalized with STEMI according to the presence of T2DM
| Men | Women | |||||
|---|---|---|---|---|---|---|
| No T2DM | T2DM | p-value | No T2DM | T2DM | p-value | |
| STEMI involving left main coronary artery, n (%) | 92 (0.59) | 92 (0.59) | NA | 28 (0.40) | 28 (0.40) | NA |
| STEMI involving left anterior descending coronary artery, n (%) | 1859 (11.99) | 1859 (11.99) | NA | 689 (9.85) | 689 (9.85) | NA |
| STEMI involving other coronary artery of anterior wall, n (%) | 3722 (24.01) | 3722 (24.01) | 1796 (25.68) | 1796 (25.68) | NA | |
| STEMI involving right coronary artery, n (%) | 2163 (13.95) | 2163 (13.95) | NA | 771 (11.02) | 771 (11.02) | NA |
| STEMI involving other coronary artery of inferior wall, n (%) | 4204 (27.12) | 4204 (27.12) | NA | 1729 (24.72) | 1729 (24.72) | NA |
| STEMI involving left circumflex coronary artery, n (%) | 293 (1.89) | 293 (1.89) | NA | 91 (1.30) | 91 (1.30) | NA |
| STEMI involving other sites, n (%) | 843 (5.44) | 843 (5.44) | NA | 386 (5.52) | 386 (5.52) | NA |
| STEMI of unspecified site, n (%) | 2327 (15.01) | 2327 (15.01) | NA | 1504 (21.50) | 1504 (21.50) | NA |
| Age, mean (SD) | 67.33 (11.88) | 67.33 (11.88) | NA | 75.87 (11.43) | 75.87 (11.43) | NA |
| CCI, mean (SD) | 0.45 (0.74) | 0.61 (0.56) | < 0.001 | 0.55 (0.47) | 0.72 (0.65) | < 0.001 |
| Obesity, n (%) | 1384 (8.93) | 2422 (15.62) | < 0.001 | 760 (10.87) | 1242 (17.76) | < 0.001 |
| Hypertension, n (%) | 6516 (42.03) | 8687 (56.03) | < 0.001 | 3566 (50.99) | 4226 (60.42) | < 0.001 |
| Lipid metabolism disorders, n (%) | 6198 (39.98) | 8922 (57.55) | < 0.001 | 2910 (41.61) | 3927 (56.15) | < 0.001 |
| Renal disease, n (%) | 1019 (6.57) | 1883 (12.15) | < 0.001 | 653 (9.34) | 1155 (16.51) | < 0.001 |
| Atrial fibrillation, n (%) | 1857 (11.98) | 1841 (11.88) | 0.779 | 1369 (19.57) | 1212 (17.33) | 0.001 |
| Congestive heart failure, n (%) | 2087 (13.46) | 2648 (17.08) | < 0.001 | 1424 (20.36) | 1870 (26.74) | < 0.001 |
| Peripheral vascular disease, n (%) | 722 (4.66) | 1166 (7.52) | < 0.001 | 186 (2.66) | 310 (4.43) | < 0.001 |
| Cerebrovascular disease, n (%) | 387 (2.50) | 621 (4.01) | < 0.001 | 277 (3.96) | 376 (5.38) | < 0.001 |
| Dementia, n (%) | 170 (1.10) | 215 (1.39) | 0.021 | 272 (3.89) | 334 (4.78) | 0.010 |
| Mechanical ventilation, n (%) | 1075 (6.93) | 1093 (7.05) | 0.689 | 429 (6.13) | 487 (6.96) | 0.047 |
| CABG, n (%) | 180 (1.16) | 235 (1.52) | 0.007 | 44 (0.63) | 52 (0.74) | 0.413 |
| PCI, n (%) | 9629 (62.11) | 9406 (60.67) | 0.009 | 3384 (48.38) | 3257 (46.57) | 0.032 |
| LOHS, median (IQR) | 5.00 (5.00) | 5.00 (5.00) | 0.650 | 5.00 (5.00) | 5.00 (5.00) | 0.921 |
| In-hospital mortality, n (%) | 1184 (7.64) | 1214 (7.83) | 0.524 | 944 (13.50) | 1091 (15.60) | < 0.001 |
STEMI ST-elevation myocardial infarction, CCI Charlson comorbidity index, CABG coronary artery bypass graft, PCI percutaneous coronary intervention, LOHS length of hospital stay, NA not applicable
The P values for the differences between patients with T2DM and No T2DM were calculated using Student’s t-test, or Mann–Whitney test or chi-square tests